glp-1 medications approved for diabetes and weight loss 2025 like Ozempic, Wegovy Mounjaro are changing and management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss ISPOR 2025: Exploring reasons for

In the US, diabetes is the most common reason for end-stage renal disease (ESRD), and is responsible for 40% of new dialysis patients

Several animal studies investigated the effects of liraglutide 122,123,124,125,126,127 and exendin-4 (refs

But in Saudi obesity care its a powerful one

as showed by the quantification of: the number and total length of master segments and the number, total meshes area and number of junctions (Fig

Efforts to repurpose semaglutide for AUD should continue apace. This is big news in a field where, in the US, only three FDA-approved, modestly effective treatments exist, and some cant be used in those with liver damage